Variant report
Variant | nsv437325 |
---|---|
Chromosome Location | chr3:24778690-24790835 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6766822 | chr3:24778690-24778691 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs567796970 | chr3:24778700-24778701 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs536700071 | chr3:24778704-24778705 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs114914488 | chr3:24778705-24778706 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs148197573 | chr3:24778719-24778720 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs116478059 | chr3:24778724-24778725 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs372488128 | chr3:24778761-24778762 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs115813820 | chr3:24778795-24778796 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs187973928 | chr3:24778836-24778837 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs78286201 | chr3:24778859-24778860 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs577406151 | chr3:24778862-24778863 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs535213330 | chr3:24778910-24778911 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs539442946 | chr3:24778918-24778919 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs192395203 | chr3:24778919-24778920 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs78375184 | chr3:24778977-24778978 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs4321478 | chr3:24779041-24779042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs141135414 | chr3:24779066-24779067 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs73820053 | chr3:24779132-24779133 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs73820054 | chr3:24779134-24779135 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs150330636 | chr3:24779178-24779179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs528320577 | chr3:24779245-24779246 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs540061768 | chr3:24779269-24779270 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs370853467 | chr3:24779277-24779278 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs137974093 | chr3:24779281-24779282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs550212949 | chr3:24779304-24779305 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs568879365 | chr3:24779358-24779359 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs532779959 | chr3:24779368-24779369 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs185541541 | chr3:24779369-24779370 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs187930013 | chr3:24779377-24779378 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs556044944 | chr3:24779419-24779420 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs571035613 | chr3:24779503-24779504 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs535307181 | chr3:24779508-24779509 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs386659412 | chr3:24779532-24779533 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs116226874 | chr3:24779533-24779534 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs536003023 | chr3:24779544-24779545 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs537468316 | chr3:24779580-24779581 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs191964635 | chr3:24779587-24779588 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs76328544 | chr3:24779609-24779610 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs111421045 | chr3:24779624-24779625 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs113081171 | chr3:24779625-24779626 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs113954081 | chr3:24779626-24779627 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs557071968 | chr3:24779634-24779635 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs6772760 | chr3:24779648-24779649 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs149520378 | chr3:24779656-24779657 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs570964650 | chr3:24779677-24779678 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs145998920 | chr3:24779690-24779691 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs561546361 | chr3:24779715-24779716 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs80157759 | chr3:24779742-24779743 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs139892558 | chr3:24779777-24779778 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs141858390 | chr3:24779783-24779784 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 20688739 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:24776200-24782600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr3:24777800-24779600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr3:24778000-24781600 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
4 | chr3:24779600-24779800 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
5 | chr3:24779600-24780200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr3:24779800-24785200 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
7 | chr3:24780200-24781600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr3:24781400-24782200 | Enhancers | Fetal Muscle Leg | muscle |
9 | chr3:24781600-24782400 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
10 | chr3:24781600-24783200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
11 | chr3:24781600-24783400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr3:24781800-24782600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
13 | chr3:24781800-24783000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
14 | chr3:24782000-24782800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
15 | chr3:24782000-24783200 | Enhancers | H1 Cell Line | embryonic stem cell |
16 | chr3:24782200-24783000 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
17 | chr3:24782200-24783200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
18 | chr3:24782600-24783800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
19 | chr3:24783400-24785600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
20 | chr3:24785200-24785400 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
21 | chr3:24787400-24787600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |